SCHEMBL6689903

SCHEMBL6689903

COc1cc2ncnc(Nc3ccc(CC=O)cc3)c2cc1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 11/20 0.63
RET P07949 5/20 0.63
KIF5B P33176 4/20 0.63
EGFR P00533 9/20 0.62
RIPK2 O43353 2/20 0.62
JAK3 P52333 2/20 0.62
GAK O14976 1/20 0.62
STK10 O94804 1/20 0.62
FLT3 P36888 1/20 0.62
AAK1 Q2M2I8 1/20 0.62
Q6ZSR9 Q6ZSR9 1/20 0.62
SLK Q9H2G2 1/20 0.62
IRAK4 Q9NWZ3 1/20 0.62
RPS6KA6 Q9UK32 1/20 0.62
ALK Q9UM73 1/20 0.62
LCK P06239 3/20 0.61
AURKB Q96GD4 2/20 0.59
PIK3CD O00329 1/20 0.58
PIK3CA P42336 1/20 0.58
PIK3CB P42338 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6689825 0.97 KDR (0.64) KDRRETKIF5BEGFRRIPK2
SCHEMBL6689322 0.91 PIK3CD (0.69) KDRRETEGFRRIPK2JAK3
SCHEMBL6684007 0.83 EGFR (0.74) KDRRETEGFRRIPK2JAK3
SCHEMBL6691545 0.83 KDR (0.60) KDRRETEGFRRIPK2JAK3
SCHEMBL14964757 0.82 EGFR (0.81) KDRRETKIF5BEGFRRIPK2
SCHEMBL5242610 0.82 KDR (0.81) KDRRETKIF5BEGFRRIPK2
SCHEMBL5239599 0.82 EGFR (0.80) KDRRETKIF5BEGFRRIPK2
SCHEMBL6689899 0.82 AURKB (0.69) KDRRETKIF5BEGFRRIPK2
SCHEMBL20792806 0.81 EGFR (0.87) KDRRETKIF5BEGFRRIPK2
SCHEMBL14159636 0.80 KDR (0.73) KDRRETKIF5BEGFRRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004069145-A2 ANTICANCER COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S LABORATORIES LTD. (IN) 2004-08-19 WO disclosed